149 related articles for article (PubMed ID: 1545407)
1. Mechanism of inositol 1,4,5-trisphosphate-induced aggregation in saponin-permeabilized platelets.
Knezevic I; Dieter JP; Le Breton GC
J Pharmacol Exp Ther; 1992 Mar; 260(3):947-55. PubMed ID: 1545407
[TBL] [Abstract][Full Text] [Related]
2. Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils.
Bleasdale JE; Thakur NR; Gremban RS; Bundy GL; Fitzpatrick FA; Smith RJ; Bunting S
J Pharmacol Exp Ther; 1990 Nov; 255(2):756-68. PubMed ID: 2147038
[TBL] [Abstract][Full Text] [Related]
3. Labeling of human platelet plasma membrane thromboxane A2/prostaglandin H2 receptors using SQB, a novel biotinylated receptor probe.
Komiotis D; Wencel-Drake JD; Dieter JP; Lim CT; Le Breton GC
Biochem Pharmacol; 1996 Sep; 52(5):763-70. PubMed ID: 8765474
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the inhibition of U46619-mediated human platelet activation by the trimetoquinol isomers. Evidence for endoperoxide/thromboxane A2 receptor blockade.
Ahn CH; Romstedt KJ; Wallace LJ; Miller DD; Feller DR
Biochem Pharmacol; 1988 Aug; 37(15):3023-33. PubMed ID: 3134894
[TBL] [Abstract][Full Text] [Related]
5. The response to thromboxane A2 analogues in human platelets. Discrimination of two binding sites linked to distinct effector systems.
Takahara K; Murray R; FitzGerald GA; Fitzgerald DJ
J Biol Chem; 1990 Apr; 265(12):6836-44. PubMed ID: 2139029
[TBL] [Abstract][Full Text] [Related]
6. 7-[(1R,2S,3S,5R)-6,6-dimethyl-3-(4- iodobenzenesulfonylamino)bicyclo[3.1.1]hept-2-yl]-5(Z)-heptenoic acid: a novel high-affinity radiolabeled antagonist for platelet thromboxane A2/prostaglandin H2 receptors.
Naka M; Mais DE; Morinelli TA; Hamanaka N; Oatis JE; Halushka PV
J Pharmacol Exp Ther; 1992 Aug; 262(2):632-7. PubMed ID: 1386885
[TBL] [Abstract][Full Text] [Related]
7. Removal of extraplatelet Na+ eliminates indomethacin-sensitive secretion from human platelets stimulated by epinephrine, ADP, and thrombin.
Connolly TM; Limbird LE
Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5320-4. PubMed ID: 6577431
[TBL] [Abstract][Full Text] [Related]
8. Metabolic and functional consequences of introducing inositol 1,4,5-trisphosphate into saponin-permeabilized human platelets.
Authi KS; Evenden BJ; Crawford N
Biochem J; 1986 Feb; 233(3):707-18. PubMed ID: 2939827
[TBL] [Abstract][Full Text] [Related]
9. Influence of heparins on inositol 1,4,5-trisphosphate-induced calcium mobilization in permeabilized human platelets.
Rao GH; Fareed J; White JG
Biochem Med Metab Biol; 1991 Apr; 45(2):171-80. PubMed ID: 1883625
[TBL] [Abstract][Full Text] [Related]
10. Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets.
Greenberg SS; Johns A; Kleha J; Xie J; Wang Y; Bianchi J; Conley K
J Pharmacol Exp Ther; 1994 Mar; 268(3):1352-61. PubMed ID: 8138950
[TBL] [Abstract][Full Text] [Related]
11. Antiplatelet effects of caffeic acid due to Ca(2+) mobilizationinhibition via cAMP-dependent inositol-1, 4, 5-trisphosphate receptor phosphorylation.
Lee DH; Kim HH; Cho HJ; Bae JS; Yu YB; Park HJ
J Atheroscler Thromb; 2014; 21(1):23-37. PubMed ID: 24088646
[TBL] [Abstract][Full Text] [Related]
12. Thromboxane-insensitive dog platelets have impaired activation of phospholipase C due to receptor-linked G protein dysfunction.
Johnson GJ; Leis LA; Dunlop PC
J Clin Invest; 1993 Nov; 92(5):2469-79. PubMed ID: 8227362
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanism of thromboxane A(2)-induced platelet aggregation. Essential role for p2t(ac) and alpha(2a) receptors.
Paul BZ; Jin J; Kunapuli SP
J Biol Chem; 1999 Oct; 274(41):29108-14. PubMed ID: 10506165
[TBL] [Abstract][Full Text] [Related]
14. Defective signal transduction through the thromboxane A2 receptor in a patient with a mild bleeding disorder: deficiency of the inositol 1,4,5-triphosphate formation despite normal G-protein activation.
Mitsui T; Yokoyama S; Shimizu Y; Katsuura M; Akiba K; Hayasaka K
Thromb Haemost; 1997 May; 77(5):991-5. PubMed ID: 9184416
[TBL] [Abstract][Full Text] [Related]
15. Further evidence against the validity of using an ADP-removing enzyme system (CP/CPK) for demonstrating the role of secreted ADP in platelet activation.
Nunn B; Chamberlain PD
Thromb Res; 1983 Apr; 30(1):19-26. PubMed ID: 6857606
[TBL] [Abstract][Full Text] [Related]
16. The roles of LAT in platelet signaling induced by collagen, TxA2, or ADP.
Cho MJ; Pestina TI; Steward SA; Jackson CW; Kent Gartner T
Biochem Biophys Res Commun; 2002 Apr; 292(4):916-21. PubMed ID: 11944902
[TBL] [Abstract][Full Text] [Related]
17. Extracellular ATP inhibits agonist-induced mobilization of internal calcium in human platelets.
Soslau G; McKenzie RJ; Brodsky I; Devlin TM
Biochim Biophys Acta; 1995 Jul; 1268(1):73-80. PubMed ID: 7626665
[TBL] [Abstract][Full Text] [Related]
18. Activation of permeabilized platelets by inositol-1,4,5-trisphosphate.
Israels SJ; Robinson P; Docherty JC; Gerrard JM
Thromb Res; 1985 Nov; 40(4):499-509. PubMed ID: 3936229
[TBL] [Abstract][Full Text] [Related]
19. Possible involvement of cytoskeleton in collagen-stimulated activation of phospholipases in human platelets.
Nakano T; Hanasaki K; Arita H
J Biol Chem; 1989 Apr; 264(10):5400-6. PubMed ID: 2494164
[TBL] [Abstract][Full Text] [Related]
20. Antiplatelet activity of carnosol is mediated by the inhibition of TXA2 receptor and cytosolic calcium mobilization.
Lee JJ; Jin YR; Lim Y; Hong JT; Kim TJ; Chung JH; Yun YP
Vascul Pharmacol; 2006 Sep; 45(3):148-53. PubMed ID: 16916624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]